eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2024
vol. 75
 
Share:
Send email
Share:
abstract:
Review paper

Exocrine pancreatic insufficiency in systemic diseases: unravelling the complex interplay – a comprehensive review

Muhammad Ali Muzammil
1
,
Laiba Imran
1
,
Jatin Motwani
2
,
Mariam Anwar
3
,
Sania Riaz
4
,
Namra Vinay Gohil
5
,
Fariha .
1
,
Aarfeen .
6

  1. Dow University of Health Sciences, Sindh, Pakistan
  2. Liaquat National Hospital and Medical College, Karachi, Pakistan
  3. Baqai Medical College, Karachi, Pakistan
  4. Allama Iqbal Medical College, Lahore, Pakistan
  5. Medical College Baroda, Gujarat, India
  6. Jinnah Sindh Medical University, Karachi, Pakistan
Pol J Pathol 2024; 75 (2): 65-76
DOI: https://doi.org/10.5114/pjp.2024.141222
Online publish date: 2024/07/07
View full text Get citation
 
PlumX metrics:
Exocrine pancreatic insufficiency (EPI) is characterised by the pancreas’s inadequate synthesis or release of digestive enzymes, which impairs digestion and causes nutritional malabsorption. To effectively manage concomitant systemic disorders and provide personalised therapy, early identification is essential. The production of digestive enzymes is a key component in the processes of EPI, which is linked to several conditions such as pancreatic cancer, cystic fibrosis, chronic pancreatitis, and diabetes-related fibrosis. Other causes include aging, smoking, inflammatory bowel disease (IBD), and stomach removal. Exocrine pancreatic insufficiency causes prolonged diarrhoea in celiac disease, perhaps resulting in pancreatitis and autoimmune processes. With mechanisms involving inflammation, bile duct scarring, pancreatic autoantibodies, and extraintestinal manifestations, EPI prevalence in IBD is noteworthy. Both indirect and direct tests are used in the diagnosis of EPI, and secretin-induced magnetic resonance cholangiopancreatography imaging provides a thorough evaluation. Modifications to lifestyle, therapy modalities such as pancreatic enzyme replacement therapy, and innovative therapies for genetic disorders are all part of the management. Pancreatic enzyme replacement treatment is important because micronutrient deficits, including calcium, magnesium, zinc, and vitamins, are present in EPI patients.

Innovative treatments investigate machine learning and PARP enzymes for prophylactic and diagnostic purposes, advancing more accurate EPI diagnosis and treatment in systemic disorders.
keywords:

exocrine pancreatic insufficiency, systemic diseases, pancreatic dysfunction, digestive enzyme deficiency, gastrointestinal disorders, multiorgan dysfunction
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.